Our Leading Pharmaceuticals

Endocannabinoid System

Development Partner

Oncology

Neurology

Dermatology

Established
Pharmaceuticals

  • Leveraging Molecules Already Approved as Drugs

  • Applying Formulation and Drug Delivery Technologies to Provide Better Dosing

  • Lower Clinical Risk Strategy 

  • Shorter Timelines to Market

Innovative
Pharmaceuticals

  • Peripherally-Restricted Proprietary Molecules Which Act on the Peripheral Endocannabinoid Receptors; CB1 & CB2

  • High Reward Prospects

  • Offers a Period of Market Exclusivity

 

Metabolism

Nephrology

Neurology

Goals & Objectives

The immediate primary objective is to secure proper financing to advance developments and to support operations. Such positioning will provide opportunities to raise additional working capital, offer liquidity to shareholders, and position the Company for future growth and profitability.

Investors
Agentix OTCM:AGTX is a Publicly Traded Company
info@agentixcorp.com

AGENTIX Corp.

Corporate Office: 32932 Pacific Coast Highway, #14-254 Dana Point, California 92629

New York Office: 309 Fifth Avenue, New York, NY 10016

Canadian Office: Unit #101 – 2275 Upper Middle Road East Oakville, Ontario L6H 0C3

Website By: Symboliq Media